GlaxoSmithKline/ News/ Sales and Marketing/ US Early filing gives GSK a boost in COPD Andrew McConaghie Anoro, Breo, COPD, respiratory 0 Comment Compelling data from FULFIL study puts GSK in pole position Share X Early filing gives GSK a boost in COPD https://pharmaphorum.com/news/early-filing-gives-gsk-boost-copd/